Walden Biosciences is a startup based in the United States, most recent round Series B, 1 tracked investor.
Walden Biosciences is a startup based in the United States. Its most recent tracked round is Series B. Brouky records 1 investor associated with the company.
Walden Biosciences is a biotechnology company focused on developing first-in-class, highly-targeted therapies for individuals living with kidney disease, particularly by addressing kidney-specific cell types and biologic processes to restore renal function.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.